Biofilm formation by Staphylococcus haemolyticus.

Area of Science:

• Microbiology
• Medical Science
• Biotechnology

Background:

• Coagulase-negative staphylococci (CoNS) frequently cause infections associated with medical devices.
• Staphylococcus haemolyticus is the second most common CoNS implicated in hospital-acquired infections.
• Understanding S. haemolyticus biofilm formation is crucial for combating device-associated infections.

Purpose of the Study:

• To characterize the biofilm-forming capacities of clinical Staphylococcus haemolyticus isolates.
• To identify the key components and structural characteristics of S. haemolyticus biofilms.
• To compare S. haemolyticus biofilm formation with that of S. epidermidis.

Main Methods:

• Analysis of biofilm formation in 72 clinical S. haemolyticus isolates under varying growth conditions (TSB with glucose vs. NaCl).
• Detachment assays using DNase, proteinase K, and NaIO(4) to determine biofilm matrix composition.
• Molecular analysis (PCR, sequencing) of biofilm-associated genes, including the ica operon.
• Confocal laser scanning microscopy (CLSM) to visualize biofilm structure.

Main Results:

• 74% of isolates formed biofilms in TSB with glucose, while only 31% did in TSB with NaCl, indicating specific induction requirements.
• Biofilm matrix was primarily composed of extracellular DNA (100% detachment with DNase) and proteins (98% detachment with proteinase K).
• Polysaccharide intercellular adhesin (PIA) and the ica operon were present in only two isolates, suggesting a minor role in S. haemolyticus biofilms.
• CLSM revealed distinct biofilm structures compared to S. epidermidis.

Conclusions:

• Biofilm formation is a prevalent characteristic of clinical Staphylococcus haemolyticus isolates.
• Proteins and extracellular DNA are critical for S. haemolyticus biofilm development, unlike the significant role of PIA in S. epidermidis.
• Optimized conditions are necessary for inducing and quantifying S. haemolyticus biofilm mass.